MX2013014142A - Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. - Google Patents
Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.Info
- Publication number
- MX2013014142A MX2013014142A MX2013014142A MX2013014142A MX2013014142A MX 2013014142 A MX2013014142 A MX 2013014142A MX 2013014142 A MX2013014142 A MX 2013014142A MX 2013014142 A MX2013014142 A MX 2013014142A MX 2013014142 A MX2013014142 A MX 2013014142A
- Authority
- MX
- Mexico
- Prior art keywords
- gastric resistant
- weight
- ethanol
- pharmaceutical
- influence
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 4
- 230000002496 gastric effect Effects 0.000 title abstract 4
- 239000002417 nutraceutical Substances 0.000 title abstract 4
- 235000021436 nutraceutical agent Nutrition 0.000 title abstract 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000011247 coating layer Substances 0.000 abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 125000002348 vinylic group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con una composición farmacéutica o nutracéutica de resistencia gástrica, que comprende un centro, que contiene un ingrediente activo farmacéutico o nutracéutico y una capa de recubrimiento de resistencia gástrica en el centro, en donde la capa de recubrimiento de resistencia gástrica comprende por lo menos 30% en peso de un copolímero de (met)acrilato, que comprende unidades polimerizadas de 10 a 40% en peso de ácido acrílico o metacrílico, 10 a 80% en peso de un éster de alquilo C4 a C18 de ácido acrílico o metacrílico y, opcionalmente, 0 a 60% en peso de otro monómero vinílico, por lo que la liberación del ingrediente activo farmacéutico o nutracéutico no es mayor de 10% bajo condiciones in vitro, a pH 1.2 después de 2 horas en un medio de acuerdo con USP, con y sin la adición de etanol al 20% (v/v).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2011060098 | 2011-06-17 | ||
| PCT/EP2012/061051 WO2012171884A1 (en) | 2011-06-17 | 2012-06-12 | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013014142A true MX2013014142A (es) | 2014-01-23 |
| MX356579B MX356579B (es) | 2018-06-05 |
Family
ID=46354217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013014142A MX356579B (es) | 2011-06-17 | 2012-06-12 | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9775815B2 (es) |
| JP (1) | JP6099638B2 (es) |
| KR (1) | KR101902602B1 (es) |
| CN (1) | CN103501768B (es) |
| AU (1) | AU2012269187A1 (es) |
| BR (1) | BR112013027484A8 (es) |
| CA (1) | CA2839525C (es) |
| ES (1) | ES2600853T3 (es) |
| HU (1) | HUE030548T2 (es) |
| IL (1) | IL228396A0 (es) |
| MX (1) | MX356579B (es) |
| RU (1) | RU2649806C2 (es) |
| WO (1) | WO2012171884A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9775815B2 (en) | 2011-06-17 | 2017-10-03 | Evonik Roehm Gmbh | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
| ES2786312T3 (es) * | 2014-11-26 | 2020-10-09 | Evonik Operations Gmbh | Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol |
| ES2909605T3 (es) * | 2017-09-14 | 2022-05-09 | Evonik Operations Gmbh | Polímero y forma de dosificación con propiedades de liberación mantenida y resistencia contra la influencia del etanol |
| EP3761967A1 (en) | 2018-03-09 | 2021-01-13 | Evonik Operations GmbH | Polymer mixture with resistance against the influence of ethanol |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| KR20210013089A (ko) | 2018-05-24 | 2021-02-03 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| CA3087238A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
| CN109232795A (zh) * | 2018-09-21 | 2019-01-18 | 佛山市森昂生物科技有限公司 | 一种防水型高韧性包衣材料的制备方法 |
| KR20210137116A (ko) * | 2019-03-11 | 2021-11-17 | 에보닉 오퍼레이션스 게엠베하 | 중합체성 매트릭스를 포함하는 투약 형태 |
| CN114026188A (zh) * | 2019-06-07 | 2022-02-08 | 日本曹达株式会社 | 微粒用的湿式涂布剂 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE9414066U1 (de) | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
| DE9414065U1 (de) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen |
| DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
| DE10011447A1 (de) | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| US20040039356A1 (en) * | 2000-10-16 | 2004-02-26 | Masayoshi Maki | Compositions for external preparations |
| IL156998A0 (en) * | 2001-12-19 | 2004-02-08 | Astrazeneca Ab | New film coating |
| DE10208335A1 (de) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
| JP3727290B2 (ja) * | 2002-07-22 | 2005-12-14 | 日本カラコン株式会社 | 腸溶性水系コーティング剤 |
| DE10250543A1 (de) | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
| MXPA04010956A (es) * | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
| US8168228B2 (en) * | 2003-10-17 | 2012-05-01 | Sandoz Ag | Antibiotic clarithromycin micropellet compositions |
| EP1694302A1 (en) * | 2003-12-15 | 2006-08-30 | Council of Scientific and Industrial Research | TASTE MASKED PHARMACEUTICAL COMPOSITIONS COMPRISING BITTER DRUG AND pH SENSITIVE POLYMER |
| DE102004011349A1 (de) | 2004-03-05 | 2005-09-22 | Basf Ag | Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten |
| US7446157B2 (en) * | 2004-12-07 | 2008-11-04 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
| DE102005024614A1 (de) * | 2005-05-25 | 2006-11-30 | Röhm Gmbh | Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug |
| DE102006051020A1 (de) | 2006-10-26 | 2008-04-30 | Evonik Röhm Gmbh | Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung |
| CN100465201C (zh) * | 2007-04-25 | 2009-03-04 | 上海大学 | 用作药物肠溶包衣材料的水溶性丙烯酸系树脂乳液的制备方法 |
| US9700520B2 (en) | 2007-09-21 | 2017-07-11 | Evonik Roehm Gmbh | PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| CN101801356B (zh) * | 2007-09-21 | 2016-10-19 | 赢创罗姆有限公司 | 耐受乙醇影响的非阿片类的pH依赖性受控释放的药物组合物 |
| KR101528957B1 (ko) | 2008-09-24 | 2015-06-17 | 에보니크 룀 게엠베하 | 에탄올의 영향에 대하여 내성을 갖는 ｐｈ-의존성 조절 방출 제약학적 오피오이드 조성물 |
| JP5453434B2 (ja) | 2008-09-24 | 2014-03-26 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | エタノールの影響に対する耐性を有するオピオイドではないｐＨ依存の制御放出の医薬組成物 |
| WO2010105673A1 (en) | 2009-03-18 | 2010-09-23 | Evonik Röhm Gmbh | Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients |
| CN102355893A (zh) | 2009-03-18 | 2012-02-15 | 赢创罗姆有限公司 | 采用含有中性乙烯基聚合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物 |
| US9775815B2 (en) | 2011-06-17 | 2017-10-03 | Evonik Roehm Gmbh | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
| CN103501767A (zh) * | 2011-06-17 | 2014-01-08 | 赢创罗姆有限公司 | 适合于药物或营养制品剂型的包衣组合物 |
| US9844511B2 (en) | 2011-06-17 | 2017-12-19 | Evonik Roehm Gmbh | Coating composition suitable for pharmaceutical or nutraceutical dosage forms |
-
2012
- 2012-06-12 US US14/114,752 patent/US9775815B2/en active Active
- 2012-06-12 WO PCT/EP2012/061051 patent/WO2012171884A1/en active Application Filing
- 2012-06-12 BR BR112013027484A patent/BR112013027484A8/pt not_active IP Right Cessation
- 2012-06-12 MX MX2013014142A patent/MX356579B/es active IP Right Grant
- 2012-06-12 RU RU2014101230A patent/RU2649806C2/ru active
- 2012-06-12 JP JP2014515149A patent/JP6099638B2/ja not_active Expired - Fee Related
- 2012-06-12 KR KR1020137033075A patent/KR101902602B1/ko active IP Right Grant
- 2012-06-12 HU HUE12729452A patent/HUE030548T2/en unknown
- 2012-06-12 CN CN201280021621.7A patent/CN103501768B/zh not_active Expired - Fee Related
- 2012-06-12 ES ES12729452.8T patent/ES2600853T3/es active Active
- 2012-06-12 AU AU2012269187A patent/AU2012269187A1/en not_active Abandoned
- 2012-06-12 CA CA2839525A patent/CA2839525C/en active Active
-
2013
- 2013-09-12 IL IL228396A patent/IL228396A0/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014101230A (ru) | 2015-07-27 |
| KR101902602B1 (ko) | 2018-09-28 |
| HUE030548T2 (en) | 2017-05-29 |
| ES2600853T3 (es) | 2017-02-13 |
| IL228396A0 (en) | 2016-10-31 |
| BR112013027484A2 (pt) | 2017-01-10 |
| US9775815B2 (en) | 2017-10-03 |
| KR20140045942A (ko) | 2014-04-17 |
| US20140141092A1 (en) | 2014-05-22 |
| RU2649806C2 (ru) | 2018-04-04 |
| CN103501768A (zh) | 2014-01-08 |
| CA2839525A1 (en) | 2012-12-20 |
| JP6099638B2 (ja) | 2017-03-22 |
| WO2012171884A1 (en) | 2012-12-20 |
| CN103501768B (zh) | 2016-11-09 |
| BR112013027484A8 (pt) | 2022-07-05 |
| AU2012269187A1 (en) | 2013-09-26 |
| MX356579B (es) | 2018-06-05 |
| CA2839525C (en) | 2019-07-02 |
| JP2014517020A (ja) | 2014-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX356579B (es) | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. | |
| WO2007006353A3 (de) | Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten | |
| EP2492330A3 (en) | Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet | |
| AU2003266351A1 (en) | Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers | |
| MX2017006858A (es) | Composición farmacéutica o nutracéutica con resistencia a la influencia del etanol. | |
| MX360389B (es) | Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico. | |
| ATE553754T1 (de) | Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser | |
| MX2011009669A (es) | Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante un revestimiento compuesto de una mezcla polimérica y excipientes. | |
| IL180849A (en) | Medicament in a multilayer form | |
| WO2011106416A3 (en) | Abuse-resistant formulations | |
| MX2017015465A (es) | Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol. | |
| UA93530C2 (ru) | Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения | |
| WO2008049657A3 (de) | Verwendung von (meth)acrylat-copolymeren in retard-arzneiformen zur verringerung des einflusses von ethanol auf die wirkstofffreisetzung | |
| WO2012085043A3 (en) | Rapidly disintegrating, solid coated dosage form | |
| WO2013095993A3 (en) | Water resistant personal care polymers | |
| MX2012001177A (es) | Composicion en polvo o granulada que consta de un copolimero, una sal de un acido graso monocarboxilico y un acido graso monocarboxilico y/o un alcohol graso. | |
| WO2013072118A3 (de) | Mittel zur temporären verformung keratinischer fasern auf grundlage einer kombination spezifischer filmbildender polymere | |
| MX2015010449A (es) | Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos. | |
| WO2012092486A3 (en) | Modified release benzimidazole formulations | |
| TW200635963A (en) | Partially neutralized anionic (meth)acrylate copolymer | |
| MX2010007578A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa. | |
| MX2010007579A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada. | |
| CA2797809A1 (en) | Enteric tablet | |
| WO2008115961A3 (en) | Sustained-release composition | |
| MX2020002790A (es) | Polimero y forma de dosis con propiedades de liberacion sostenida y resistencia contra la influencia de etanol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |